Sonja Textor
Overview
Explore the profile of Sonja Textor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Textor S, Bossler F, Henrich K, Gartlgruber M, Pollmann J, Fiegler N, et al.
Oncoimmunology
. 2016 Sep;
5(7):e1116674.
PMID: 27622013
Natural Killer (NK) cells are innate effector cells that are able to recognize and eliminate tumor cells through engagement of their surface receptors. NKp30 is a potent activating NK cell...
2.
Gaiser M, Textor S, Senger T, Schadlich L, Waterboer T, Kaufmann A, et al.
J Dermatol Sci
. 2014 Dec;
77(1):37-45.
PMID: 25439730
Background: Infection with different species of cutaneous human papillomaviruses (cHPV) of genus alpha (cαHPVs) and associated skin disease are highly prevalent in solid organ transplant recipients (OTR), documenting the importance...
3.
Schlecker E, Fiegler N, Arnold A, Altevogt P, Rose-John S, Moldenhauer G, et al.
Cancer Res
. 2014 May;
74(13):3429-40.
PMID: 24780758
Natural killer (NK) cells are potent immune effector cells capable of mediating antitumor responses. Thus, during immunoediting, tumor cell populations evolve strategies to escape NK-cell-mediated recognition. In this study, we...
4.
Fiegler N, Textor S, Arnold A, Rolle A, Oehme I, Breuhahn K, et al.
Blood
. 2013 Jun;
122(5):684-93.
PMID: 23801635
Natural killer (NK) cells are central effector cells during innate immune responses against cancer. Natural cytotoxicity receptors expressed by NK cells such as NKp30 are involved in the recognition of...
5.
Textor S, Fiegler N, Arnold A, Porgador A, Hofmann T, Cerwenka A
Cancer Res
. 2011 Jul;
71(18):5998-6009.
PMID: 21764762
Natural killer (NK) cells are immune cells sensing and eliminating foreign, stressed, transformed, and senescent cells through specialized surface receptors, such as NKG2D, that interacts with several virus- or stress-inducible...
6.
Textor S, Accardi R, Havlova T, Hussain I, Sylla B, Gissmann L, et al.
Int J Cancer
. 2010 May;
128(5):1104-13.
PMID: 20473930
NK cell recognition of tumor cells is mediated by a delicate balance of signals received by MHC class I-binding inhibitory NK cell receptors and activating NK cell receptors, which mainly...
7.
Senger T, Schadlich L, Textor S, Klein C, Michael K, Buck C, et al.
Vaccine
. 2009 Dec;
28(6):1583-93.
PMID: 20003923
The potential as prophylactic vaccines of L1-based particles from cutaneous genus alpha human papillomavirus (HPV) types has not been assessed so far. However, there is a high medical need for...
8.
Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, et al.
Int J Cancer
. 2008 Dec;
124(7):1594-604.
PMID: 19089914
NKG2D operates as an activating receptor on natural killer (NK) cells and costimulates the effector function of alphabeta CD8(+) T cells. Ligands of NKG2D, the MHC class I chain-related (MIC)...
9.
Textor S, Durst M, Jansen L, Accardi R, Tommasino M, Trunk M, et al.
Int J Cancer
. 2008 Aug;
123(10):2343-53.
PMID: 18712710
Human papillomavirus-induced cervical carcinomas often show impaired expression of MHC class I molecules resulting in the inability of tumor cells to directly present viral peptides to cytotoxic T lymphocytes. Loss...
10.
Hoffmann S, Schellack C, Textor S, Konold S, Schmitz D, Cerwenka A, et al.
J Biol Chem
. 2007 Jun;
282(31):22370-5.
PMID: 17562706
Activation of immune cells has to be tightly controlled to prevent detrimental hyperactivation. In this regulatory process molecules of the C-type lectin-like family play a central role. Here we describe...